Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00833222 · ClinicalTrials.gov registry record
Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 72
- Enrollment target
NCT00833222: Completed study, sponsored by University of Utah.
NCT00833222 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00833222 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to test the feasibility of measuring body composition by air displacement plethysmography (ADP) in rapidly growing, medically stable late gestation \[32-35 weeks post-menstrual age (PMA)\] premature infants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-06 |
What the finished NCT00833222 record still lists
NCT00833222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00833222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00833222 about?
NCT00833222 is a clinical study titled "Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants". The purpose of this study is to test the feasibility of measuring body composition by air displacement plethysmography (ADP) in rapidly growing, medically stable late gestation \[32-35 weeks post-menstrual age (PMA)\] premature infants.
What is the current status of trial NCT00833222?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2008-01. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00833222?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia